Kaposi's sarcoma in transplant recipients

Transplantation

Volumn 64, Issue 5, 1997, Pages 669-673

  Penn, Israel ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; BLEOMYCIN; ETOPOSIDE; FOSCARNET; GANCICLOVIR; INTERLEUKIN 6; MITOXANTRONE; ONCOSTATIN M; TUMOR NECROSIS FACTOR ALPHA; VINBLASTINE; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CLINICAL FEATURE; ETHNIC GROUP; HERPES VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INTRALESIONAL DRUG ADMINISTRATION; KAPOSI SARCOMA; KAPOSI SARCOMA ASSOCIATED HERPES VIRUS; MALIGNANT TRANSFORMATION; MITOGENESIS; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE;

ADOLESCENT; ADULT; AFRICA; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; SARCOMA, KAPOSI;

EID: 0030924513     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199709150-00001     Document Type: Review

References (52)

1. Kaposi M. Idiopathic multiple pigmented sarcoma of the skin (translated from German). Arch Dermatol Syphilol 1872; 4: 265.
2. Oettlé AG. Geographical and racial differences in the frequency of Kaposi's sarcoma as evidence of environmental or genetic causes. Acta Unio Int Contra Cancrum 1962; 18: 330.
3. Templeton AC. Kaposi's sarcoma. In: Andrade R, Gumport SL, Popkin GL, Rees TD, eds. Cancer of the skin: biology-diagnosis-management, vol. 2. Philadelphia: W.B. Saunders, 1976: 1183.
4. Harwood AR, Osoba D, Hofstader SL, et al. Kaposi's sarcoma in recipients of renal transplants. Am J Med 1979; 67(5): 759.
5. Volberding PA. Kaposi's sarcoma and the acquired immunodeficiency syndrome. Med Clin North Am 1986; 70: 665.
6. Dorfman RF, Wood GS, Beckstead JH. Histogenesis. In: Ziegler JL, Dorfman RF, eds. Kaposi's sarcoma: pathophysiology and clinical management. New York: Marcel Dekker, 1988: 71.
7. Bayley AC. Aggressive Kaposi's sarcoma in Zambia. Lancet 1984; 1: 1318.
8. Report of the centers for disease control task force on Kaposi's sarcoma and opportunistic infections. N Engl J Med 1982; 306: 248.
9. Safai B, Diaz B, Schwartz J. Malignant neoplasms associated with human immunodeficiency virus infection. CA Cancer J Clin 1992; 42: 74.
10. Penn I. Malignancy. Surg Clin North Am 1994; 74: 1247.
11. Penn I. Kaposi's sarcoma in organ transplant recipients: report of 20 cases. Transplantation 1979; 27: 8.
12. Penn I. Kaposi's sarcoma in immunosuppressed patients. J Clin Lab Immunol 1983; 12: 1.
13. Penn I. Kaposi's sarcoma. etiology: immunodeficiency. In: Ziegler JL, Dorfman RF, eds. Kaposi's sarcoma. pathophysiology and clinical management. New York: Marcel Dekker, 1988: 129.
14. Penn I. Sarcomas in organ allograft recipients. Transplantation 1995; 60: 1485.
15. Ziegler JL, Dorfman RF. Overview of Kaposi's sarcoma: history, epidemiology, and biomedical features. In: Ziegler JL, Dorfman RF, eds. Kaposi's sarcoma: pathophysiology and clinical management. New York: Marcel Dekker, 1988: 2.
16. Al-Sulaiman MH, Mousa DH, Rassoul Z, Abdalla AH, Abdur Rehman M, Al-Khader AA. Transplant-related Kaposi's sarcoma in children. Nephrol Dial Transplant 1994; 9: 443.
17. Bismuth H, Samuel D, Venancie PY, Menouar G, Szekely AM. Development of Kaposi's sarcoma in liver transplant recipients: characteristics, management and outcome. Transplant Proc 1991; 23: 1438.
18. Farge D. Kaposi's sarcoma in organ transplant recipients: the collaborative transplantation research group of the Ile de France. Eur J Med 1993; 2: 339.
19. Gluckman E, Parquet N, Scieux C, et al. KS-associated herpesvirus-like DNA sequences after allogeneic bone-marrow transplantation [Letter]. Lancet 1995; 346: 1558.
20. Helg C, Addatto M, Salomon D, et al. Kaposi's sarcoma following allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 14: 999.
21. Montagnino G, Bencini PL, Tarantino A, Caputo R, Ponticelli C. Clinical features and course of Kaposi's sarcoma in kidney transplant patients: report of 13 cases. Am J Nephrol 1994; 14: 121.
22. Al-Sulaiman MH, Al-Khader AA. Kaposi's sarcoma in renal transplant recipients. Transplant Sci 1994; 4: 46.
23. Qunibi W, Akhtar M, Sheth K, et al. Kaposi's sarcoma: the most common tumor after renal transplantation in Saudi Arabia. Am J Med 1988; 84: 225.
24. Shmueli D, Shapira Z, Yussim A, Nakache R, Ram Z, Shaharabani E. The incidence of Kaposi's sarcoma in renal transplant patients and its relation to immunosuppression. Transplant Proc 1989; 21: 3209.
25. Penn I. Cancers in cyclosporine-treated versus azathioprine-treated patients. Transplant Proc 1996; 28: 876.
26. Safai B, Miké V, Giraldo G, Beth E, Good RA. Association of Kaposi's sarcoma with second primary malignancies: possible etiopathogenic implications. Cancer 1980; 45: 1472.
27. Touraine JL, Garnier JL, LeFrancois N, et al. Severe lymphoproliferative disease and Kaposi's sarcoma in transplant patients. Transplant Proc 1989; 21: 3197.
28. Myers BD, Kessler E, Levi J, Pick A, Rosenfeld JB. Kaposi's sarcoma in kidney transplant recipients. Arch Int Med 1974; 133: 307.
29. Gunawardena KA, Al-Hasani MK, Haleem A, Al-Suleiman M, Al-Khader AA. Pulmonary Kaposi's sarcoma in two recipients of renal transplants. Thorax 1988; 43: 653.
30. Margolius L, Stein M, Spencer D, Bezwoda WR. Kaposi's sarcoma in renal transplant recipients: experience at Johannesburg Hospital 1966-1989. South Afr Med J 1994; 84: 16.
31. Qunibi WY, Barri Y, Alfurayh O, et al. Kaposi's sarcoma in renal transplant recipients: a report on 26 cases from a single institution. Transplant Proc 1993; 25: 1402.
32. Doutrelepont JM, De Pauw L, Gruber SA, et al. Renal transplantation exposes patients with previous Kaposi's sarcoma to a high risk of recurrence. Transplantation 1996; 62: 463.
33. Warner TF, O'Loughlin S. Kaposi's sarcoma: a byproduct of tumor rejection. Lancet 1975; 2: 687.
34. Ziegler JL. Etiology: angiogenesis. In: Ziegler JL, Dorgman RF, eds. Kaposi's sarcoma: pathophysiology and clinical management. New York: Marcel Dekker, 1988: 151.
35. Pober JS, Collins T, Gimbrone MA, et al. Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant interferon. Nature 1983; 305: 726.
36. Brunson ME, Balakrishnan K, Penn I. HLA and Kaposi's sarcoma in solid organ transplantation. Hum Immunol 1990; 29: 56.
37. Brooks JJ. Kaposi's sarcoma: a reversible hyperplasia. Lancet 1986; 2: 1309.
38. Dalgleish AG. Kaposi's sarcoma. Br J Cancer 1991; 64: 3.
39. Huang YQ, Li JJ, Rush MG, et al. HPV-16-related DNA sequences in Kaposi's sarcoma. Lancet 1992; 339: 515.
40. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med 1995; 332: 1181.
41. Roizman B. New viral footprints in Kaposi's sarcoma. N Engl J Med 1995; 332: 1227.
42. Kedda M-A, Margolius L, Kew MC, Swanepoel C, Pearson D. Kaposi's sarcoma-associated herpesvirus in Kaposi's sarcoma occurring in immunosuppressed renal transplant recipients. Clin Transplant 1996; 10: 429.
43. Rady PL, Yen A, Rollefsonson JL, et al. Herpes-like DNA sequences in non-Kaposi's sarcoma skin lesions of transplant patients. Lancet 1995; 345: 1339.
44. Kempf W, Adams V. Viruses in the pathogenesis of Kaposi's sarcoma - a review. Biochem Mol Med 1996; 58: 1.
45. Chang Y, Moore PS. Kaposi's sarcoma (KS)-associated herpesvirus and its role in KS. Infectious Agents Dis 1996; 5: 215.
46. Russo JJ, Bohenzhy RA, Chien MC, et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci USA 1996; 93: 14862.
47. Warmuth I, Moore PS. Kaposi sarcoma, Kaposi-sarcoma-associated herpesvirus, and human T-cell lymphotrophic virus type 1: what is the current evidence for causality? [Editorial]. Arch Dermatol 1997; 133: 83.
48. Zhong W, Wang H, Herndier B, Ganem D. Restricted expression of Kaposi-sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc Natl Acad Sci USA 1996; 93: 6641.
49. Miles SA. Pathogenesis of human immunodeficiency virus-related Kaposi's sarcoma. Curr Opin Oncol 1992; 4: 875.
50. Ensoli B, Barillari G, Gallo RC. Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma. Immunol Rev 1992; 127: 147.
51. Roth WH. TGFβ and TGF-like growth factors involved in the pathogenesis of AIDS-associated Kaposi's sarcoma. Res Virol 1993; 144: 105.
52. Stürzl M, Roth WK, Brockmeyer NH, Zietz C, Speiser B, Hofschneider PH. Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance. Proc Natl Acad Sci USA 1992; 89: 7046.